Raymond James Financial
IRMD icon

Raymond James Financial’s iRadimed IRMD Stock Holding History

Raymond James Financial’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,568
Closed -$1.29M – 5491
2026
Q1 		$1.29M Sell
13,568
-20,180
-60% -$2.02M ﹤0.01% 3680
2025
Q4 		$3.29M Sell
33,748
-7,794
-19% -$669K ﹤0.01% 2852
2025
Q3 		$2.96M Sell
41,542
-1,410
-3% -$93.9K ﹤0.01% 2874
2025
Q2 		$2.57M Buy
42,952
+1,918
+5% +$105K ﹤0.01% 2871
2025
Q1 		$2.15M Sell
41,034
-1,136
-3% -$63.8K ﹤0.01% 2929
2024
Q4 		$2.32M Buy
+42,170
New +$2.22M ﹤0.01% 2858

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Raymond James Financial's IRMD Position: Q2 2026 in Review

Raymond James Financial sold out of iRadimed (IRMD) in Q2 2026, closing a stake of 13,568 shares — an estimated $1.29M sold.

Raymond James Financial first reported a position in IRMD in Q4 2024 and held it in 6 quarters. The position peaked at $3.29M in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Raymond James Financial reported no remaining iRadimed position as of Q2 2026 after selling out during the quarter.
  • Raymond James Financial sold 13,568 iRadimed shares in Q2 2026, an estimated $1.29M.
  • Raymond James Financial first reported a position in iRadimed in Q4 2024 and held it in 6 quarters.
  • Raymond James Financial's iRadimed position peaked at $3.29M in Q4 2025.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.